REFERENCES
- Clamen N. Biologja imunog odgovora. JAMA Jugosl izdanje Beograd maj 1989; spec br: 10-16.
- Vanky F, Wang P, Lsuzsa V, Klein E. Auto-tumor reac-tivites in patients with lung and ovarian carcinomas. 8th International Congress of Immunology. Budapest, Hungary, August 23-28, 1992.
- Lacki J, Markowska J, Wiktorowicz Z. Phenotype of lymphocyte in ovarian tumor peritoneal fluid. Eur J Gynaecol Oncol 1992; X11116: 475-479.
- Barber H. Present status of tumor immunology in clini-cal gynecology. Am J Repro Immunol 1989; 20/4: 140–146.
- Kinugasa M, Akahori T, Machizuki M, Hasegawa K. Distribution of lymphocyte subsets in regional lymph nodes in uterine cervical cancer and its immunological significance. Nippon Sanka Fujinka G.Z. 1991; 43 (4): 383–390.
- Ikarashi H., Fujita K, Takakuwa T, et al. Immunomodulation in patients with epithelial ovarian cancer after adoptive transfer of tumor-infiltrating lymphocytes. Cancer Res 1994; 54 (1): 190–196.
- Meliolo G, Ferrari J, Casartelli G, Ragui N. Lymphocytes isolated from the peritoneal fluid of women with advanced ovarian carcinoma differ significantly from autologous peripheral blood lymphocytes. Gynecol Oncol 1993; 48 (3): 301–307.
- Penn I. Cancer is complication of severe immunosup-pression. Surg Gynecol Obstet 1986; 162/6: 603–610.
- Garzetti G, Posatti L, Ciavattini E, et al. Immuno-bio-logic integration for therapeutic approach in ovarian carcino-ma. Eur J Gynaecol Oncol 1992; XIII/5: 514-521.